JBS JBS
Company Profile ↓Company Overview
JBS (JBS) is a publicly traded company listed on with a market capitalization of $15.93B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 23.3%, reflecting efficient use of shareholder capital.
Trades at an undemanding P/E of 7.2.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $86.18B (+11.7% YoY); net profit $2.02B.
- Trailing 12 Months Year-on-year growth — revenue +11.7%, earnings +14.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.9%, profit CAGR -12.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.88% |
| 1 Year: | 11.66% |
Compounded Profit Growth
| 5 Years: | -12.26% |
| 1 Year: | 14.57% |
Stock Price Performance
| 1 Year: | +6.23% |
| 6 Months: | -7.34% |
| 3 Months: | -8.88% |
| 1 Month: | +12.39% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)62.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 23.3%.
- Generates positive free cash flow.
CONS
- Earnings shrank at -12.3% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 19.53B | 21.70B | 22.60B | 23.06B | 21.61B |
| Cost of Revenue | 16.90B | 18.78B | 19.62B | 20.19B | 19.28B |
| Gross Profit | 2.62B | 2.93B | 2.97B | 2.87B | 2.32B |
| Operating Expenses | 1.65B | 1.73B | 1.75B | 1.92B | 1.83B |
| Operating Income | 972.28M | 1.19B | 1.22B | 950.62M | 496.79M |
| EBITDA | 1.64B | 1.45B | 2.15B | 1.40B | 1.40B |
| Interest Expense | 414.74M | 391.00M | 480.20M | 404.76M | 469.54M |
| Pretax Income | 694.10M | 761.31M | 815.34M | 374.36M | 308.69M |
| Tax Provision | 137.77M | 146.97M | 171.22M | -60.66M | 67.10M |
| Net Income | 500.22M | 545.87M | 580.89M | 415.14M | 220.59M |
| Diluted EPS | 0.47 | 0.49 | 0.52 | 0.39 | 0.20 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 72.61B | 72.92B | 77.18B | 86.18B |
| Cost of Revenue | - | 61.07B | 64.95B | 65.59B | 74.88B |
| Gross Profit | - | 11.54B | 7.97B | 11.59B | 11.30B |
| Operating Expenses | - | 6.82B | 6.75B | 6.83B | 7.00B |
| Operating Income | - | 4.73B | 1.22B | 4.75B | 4.30B |
| EBITDA | - | 6.80B | 3.62B | 6.55B | 6.61B |
| Interest Expense | - | 1.34B | 1.73B | 1.65B | 1.68B |
| Pretax Income | - | 3.55B | -259.73M | 2.71B | 2.62B |
| Tax Provision | - | 409.96M | -127.99M | 743.39M | 390.51M |
| Net Income | - | 3.00B | -198.87M | 1.77B | 2.02B |
| Diluted EPS | - | 1.34 | -0.19 | 1.65 | 1.89 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 39.89B | 42.58B | 40.69B | 45.16B |
| Current Assets | - | 15.22B | 16.24B | 17.12B | 18.44B |
| Cash & Equivalents | - | 2.53B | 4.57B | 5.61B | 4.57B |
| Inventory | - | 7.25B | 6.81B | 6.62B | 7.93B |
| Receivables | - | 3.88B | 3.39B | 3.74B | 4.23B |
| Total Liabilities | - | 30.34B | 32.87B | 32.55B | 35.63B |
| Current Liabilities | - | 10.57B | 9.90B | 11.66B | 11.54B |
| Long Term Debt | - | 15.69B | 18.93B | 17.24B | 20.26B |
| Total Debt | - | 18.17B | 21.55B | 19.95B | 22.86B |
| Total Equity | - | 8.90B | 9.03B | 7.09B | 8.70B |
| Shares Outstanding | - | 2.22B | 2.22B | 2.22B | 1.16B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.58B | 2.38B | 4.23B | 2.93B |
| Investing Cash Flow | - | -2.54B | -1.41B | -1.42B | -2.31B |
| Financing Cash Flow | - | -1.67B | 1.02B | -1.41B | -1.77B |
| Capital Expenditure | - | -2.18B | -1.51B | -1.49B | -2.11B |
| Free Cash Flow | - | 399.56M | 867.65M | 2.74B | 825.56M |
| Net Change in Cash | - | -1.62B | 1.99B | 1.40B | -1.15B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 15.9% | 10.9% | 15.0% | 13.1% |
| Operating Margin % | - | 6.5% | 1.7% | 6.2% | 5.0% |
| Net Margin % | - | 4.1% | -0.3% | 2.3% | 2.3% |
| ROE % | - | 33.7% | -2.2% | 24.9% | 23.3% |
| ROCE % | - | 16.1% | 3.7% | 16.4% | 12.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for JBS
Earnings Preview: JBS N.V. (JBS) Q2 Earnings Expected to Decline - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOa2hHdFRmUHhyeTNQUzFUcmY2WGI1bXlGTWUxZklzNzM1X3hvMnl3dVAwN1hSMHdTSXNLNW8tR2JBWTJFVVBzZEdKd3ozRnQ1YlBwc28zRnZFQ2t0c2VxUFpoYjBwQ05LMFd0dzU1RDJ4TDBMQnJOTlhmWG9kbFViWklLV3g0RTc3R2VyYk…
U.S. reopens Mexican cattle imports as Tyson, JBS surge - Farm Progress
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPZGN1bEwzTWVEOWFMaDRPd3d5N0prY3lJSzlYVjdlWjFjYmI3SnlsVkZhNmFIb3NnZTJLVS1RLXpac1JQRVhvYktkSWJ1UzhwN3Y4dGZ0dlJ0dk5TTVBuVUF2Y1NlYjYybmN4VUlFSlJCSFdrNF9HMXVBbXhuM3Zob2pMaWc0NzllR29QY0…
Tyson and JBS Shares Jump as US to Resume Mexico Cattle Shipments - Bloomberg.com
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOSlRNRENTYm5KRGVVN1JpX2RuZExCeUdEQURkdmNsa3hxTkhzTC1EVnZmZ1hSbWVuM0hRcnZoQldPaFY1aFpXMWY4UDJEX2Q0cl9PcXhZNHExWG9OVTRSVEs2bGxiWlNlMi10SUFZanFHWm5wSzJGUURJRjJkT2NYMWdFcW9yMHI2LWtsNE…
JBS Stock Price and Chart — NYSE:JBS - TradingView
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBhMWNnMHdydVRHSGp4OFAxcmFCMGRIdG84TjQ1dkg5MDZUQU5ZOF9mUXFOSEtfUmFEd0dlUk5uNmMxWldBQVluWGY1ejdZUGxWMEc5aXQwWEg?oc=5" target="_blank">JBS Stock Price and Chart — NYSE:JBS</a> &n…
Why is JBS stock surging today? - Investing.com
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQSEdoWTRXWDdNNlFXTnFGbkZNRVFhSG93bDFwOHJlT0F0ek9iOGtfa2YwREI5Q1BrcmVDaFZlbkI5a2JCbjFPUElMd0YxaktKS0hCb3pqYzZQVEZKelZrMnBuRVMtTEZLRS12YTNMa1F4Qm10MjBpQm9hYnpYTmdKblZhMjZnbG9CUS0zMT…
Wall Street Zen Upgrades JBS (NYSE:JBS) to "Hold" - MarketBeat
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNbHRLZ3hEc1Y5X0tHeXBjZ2h3WHlxQXFQRE9UdW1qcl9YN0lUdGxhdTJRckZnV1pod2ZEVUh5RzJCWDlfbUV5aFgza3N4QkVqVUc2cWFoank3YWVWem5XandEaHlvbUJVazVWd25pQlZFSzJyZUFxNC1BRy00UFBWc0g2RDNURUdXUXJ2eF…
JBS — Frequently Asked Questions
What is the current share price of JBS?
As of 2026-08-05 17:25 PDT, JBS trades at $13.70 on NASDAQ/NYSE. Its 52-week range is $11.60 to $17.05.
What is the market capitalisation of JBS?
JBS has a market capitalisation of $15.93B on NASDAQ/NYSE.
What is the P/E ratio of JBS?
JBS trades at a trailing price-to-earnings (P/E) ratio of 7.25. Its price-to-book (P/B) ratio is 1.83.
What is the return on equity (ROE) of JBS?
JBS has a return on equity (ROE) of 23.26%. Its return on capital employed (ROCE) is 12.80%.
Is JBS a good stock to buy?
This page provides a data-driven analysis of JBS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.